Genetically engineered biological agents in therapy for systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a prototype for chronic autoimmune disease. Its prevalence is 20 to 70 cases per 100,000 women and varies by race and ethnicity. Despite considerable progress in traditional therapy, many problems associated with the management of these patients need to be immed...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Russo |
| Cyhoeddwyd: |
IMA-PRESS LLC
2013-10-01
|
| Cyfres: | Современная ревматология |
| Pynciau: | |
| Mynediad Ar-lein: | https://mrj.ima-press.net/mrj/article/view/493 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|